261 related articles for article (PubMed ID: 15289308)
1. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
3. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
Guan B; Yue P; Clayman GL; Sun SY
J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.
Shetty S; Graham BA; Brown JG; Hu X; Vegh-Yarema N; Harding G; Paul JT; Gibson SB
Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the human death receptor 4 is regulated by activator protein 1.
Guan B; Yue P; Lotan R; Sun SY
Oncogene; 2002 May; 21(20):3121-9. PubMed ID: 12082627
[TBL] [Abstract][Full Text] [Related]
7. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
Mukhopadhyay T; Roth JA
Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
9. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment.
Mendoza FJ; Ishdorj G; Hu X; Gibson SB
Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578
[TBL] [Abstract][Full Text] [Related]
10. A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway.
Li C; Chen H; Ding F; Zhang Y; Luo A; Wang M; Liu Z
Biochem J; 2009 Aug; 422(2):363-72. PubMed ID: 19534726
[TBL] [Abstract][Full Text] [Related]
11. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein.
Lee Y; Chen Y; Chang LS; Johnson LF
Exp Cell Res; 1997 Aug; 234(2):270-6. PubMed ID: 9260894
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
14. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
15. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
16. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Kazhdan I; Marciniak RA
Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
[TBL] [Abstract][Full Text] [Related]
17. Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.
Sun M; Zhang J; Liu S; Liu Y; Zheng D
Oncol Rep; 2008 Jan; 19(1):177-85. PubMed ID: 18097593
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
19. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
[TBL] [Abstract][Full Text] [Related]
20. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
Yang AL; Festing MF
Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]